• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INOGEN MINI ICD DR; IMPLANTABLE DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INOGEN MINI ICD DR; IMPLANTABLE DEVICE Back to Search Results
Model Number D013
Medical Device Problem Codes Inappropriate/Inadequate Shock/Stimulation (1574); Telemetry Discrepancy (1629); Noise, Audible (3273)
Health Effect - Clinical Codes Electric Shock (2554); No Code Available (3191)
Date of Event 08/31/2020
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).The product has been received for analysis.This report will be updated upon completion of analysis.
 
Event or Problem Description
It was reported that this implantable cardioverter defibrillator (icd) was unable to be interrogated during a routine follow up.This device was also reported to have emitted beeping tones.A changeout procedure was scheduled.Prior to change out, the patient reported receiving nine shocks due to atrial fibrillation (af).This device was then explanted and replaced.No additional adverse patient effects were reported.
 
Additional Manufacturer Narrative
Patient code 3191 was applied to capture the reportable event of surgery.The product has been received for analysis.This report will be updated upon completion of analysis.The returned device was thoroughly inspected and analyzed upon receipt at our post market quality assurance laboratory.Visual examination of the device header and case noted no anomalies.The device was then exposed to simulated heart load conditions, and the defibrillation, pacing, and sensing functions were tested.Impedance testing was completed and all measurements were within normal limits.The device operated appropriately with no interruptions in therapy output at the returned programmed settings.A series of electrical tests was also performed, and again, normal device function was observed.Analysis did not identify any device characteristics that would have caused or contributed to the reported clinical observations.
 
Event or Problem Description
It was reported that this implantable cardioverter defibrillator (icd) was unable to be interrogated during a routine follow up.This device was also reported to have emitted beeping tones.A changeout procedure was scheduled.Prior to change out, the patient reported receiving nine shocks due to atrial fibrillation (af).This device was then explanted and replaced.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INOGEN MINI ICD DR
Common Device Name
IMPLANTABLE DEVICE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key10636807
Report Number2124215-2020-19294
Device Sequence Number2604477
Product Code LWS
UDI-Device Identifier00802526533846
UDI-Public00802526533846
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P960040/S306
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2015
Device Explanted Year2020
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 06/24/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Lay User/Patient
Device Expiration Date06/12/2016
Device Model NumberD013
Device Catalogue NumberD013
Device Lot Number102156
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/15/2020
Initial Date Received by Manufacturer 08/31/2020
Supplement Date Received by Manufacturer04/05/2021
Initial Report FDA Received Date10/06/2020
Supplement Report FDA Received Date06/24/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age63 YR
-
-